Skip to main
ATNM
ATNM logo

Actinium Pharmaceuticals (ATNM) Earnings Dates & Reports

Actinium Pharmaceuticals (ATNM) Most Recent Earnings

Report DateAug 8, 2025
Period EndingQ2 2025
Est. EPS-$0.30
Actual EPS-$0.22
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Actinium Pharmaceuticals (ATNM) Earnings per Share (EPS) History

Signup for full access
Browse free

Actinium Pharmaceuticals (ATNM) Latest Earnings

The value each ATNM share was expected to gain vs. the value each share gained.

Actinium Pharmaceuticals (ATNM) reported its most recent earnings on Aug 8, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.22. This exceeded analysts' expectations of -$0.30 by 26.67%, marking a Beat.

For comparison, Actinium Pharmaceuticals reported EPS of -$0.38 in the same quarter last year.

The company is expected to announce its next earnings report on 11/13/2025, with analysts projecting an EPS of -$0.30.

Actinium Pharmaceuticals (ATNM) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q3 2025Nov 13, 2025
-$0.30Next earnings call Nov. 13, 2025
Q2 2025Aug 8, 2025
-$0.30-$0.22-26.67%
Q1 2025May 9, 2025
-$0.36-$0.51+41.67%
Q4 2024Mar 31, 2025
-$0.29-$0.21-27.59%
Q3 2024Nov 14, 2024
-$0.36-$0.37+2.78%
View all

Actinium Pharmaceuticals (ATNM) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Actinium Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Aug 8, 2025
May 9, 2025
Mar 31, 2025
Nov 14, 2024

Actinium Pharmaceuticals (ATNM) Earnings FAQs

Actinium Pharmaceuticals (ATNM) last reported earnings on Aug 8, 2025 for Q2 2025, posting an EPS of -$0.22, which Beat the estimate of -$0.30 by 26.67%.

For Q2 2025, Actinium Pharmaceuticals (ATNM) reported an EPS of -$0.22, exceeding analysts' estimate of -$0.30 by 26.67%.

For Q2 2025, Actinium Pharmaceuticals (ATNM) Beat expectations with an actual EPS of -$0.22 vs. an estimated EPS of -$0.30.

Following the last earnings report on Aug 8, 2025, Actinium Pharmaceuticals (ATNM)'s stock price moved — from — to —.

The next Actinium Pharmaceuticals (ATNM) earnings call is scheduled for Nov. 13, 2025, where executives will discuss financial results and outlook.

Actinium Pharmaceuticals (ATNM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.